MedTech Acquisition Corporation (MTAC)
$11.34
+1.78 (+18.67%)
Rating:
Recommendation:
-
| Symbol | MTAC |
|---|---|
| Price | $11.34 |
| Beta | -0.021 |
| Volume Avg. | 0.01M |
| Market Cap | 83.857M |
| Shares () | - |
| 52 Week Range | 8.43-12.8299 |
| 1y Target Est | - |
| DCF Unlevered | MTAC DCF -> | |
|---|---|---|
| DCF Levered | MTAC LDCF -> | |
| ROE | 1.84% | Neutral |
| ROA | 10.99% | Buy |
| Operating Margin | - | |
| Debt / Equity | 47.79% | Neutral |
| P/E | 226.80 | Strong Buy |
| P/B | 14.74 | Strong Buy |
Latest MTAC news
About
Download (Excel)MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.